Common Misconceptions About Metabolic Flexibility

Metabolic flexibility (MetFlex) is the capacity to shift between carbohydrate and lipid oxidation in response to nutrient availability [2]. It is a functional readout of substrate metabolism rather than a single molecule, and it has no sequence, formula or molecular weight. In the research literature it is assessed by indirect calorimetry, including whole-room calorimetry, and paired with mitochondrial function measures such as high-resolution respirometry in peripheral blood mononuclear cells (PBMCs) [2].

The work centres on mitochondrial substrate handling and the signalling pathways that regulate oxidative metabolism, including the sirtuin (SIRT) family, particularly SIRT1 and SIRT3, and the AMPK-PGC-1α-SIRT3 axis [6][8].

Research Studies

Metabolic flexibility and extreme obesity (BMI ≥60 kg/m²)

A clinical trial is evaluating energy metabolism (expenditure and fat oxidation) and metabolic flexibility in response to a high-fat test meal in 10 individuals with a BMI ≥60 kg/m², using gold-standard assessments of energy metabolism, metabolic flexibility and body composition. Males and females aged 18–80 years are being recruited from Baton Rouge, Louisiana. Exclusion criteria include major organ failure, uncontrolled endocrine disease, severe psychiatric illness, pregnancy, and inability to comply with study procedures. Total participation is estimated at approximately 10 days [1].

Whole grape polyphenols and postprandial substrate shift

Obesity is associated with reduced metabolic flexibility [2]. Grape polyphenols (resveratrol, catechins, quercetin, epicatechin) enhance fat oxidation and mitochondrial function in laboratory and animal studies, but whole grapes, rather than purified extracts, have not been tested for acute effects on MetFlex measured directly by whole-room calorimetry paired with mitochondrial function. A trial integrates whole-room indirect calorimetry with high-resolution respirometry in PBMCs to determine whether whole grape polyphenols shift the postprandial response [2].

Mediterranean diet and metabolic flexibility in mild cognitive impairment

In a 24-week intervention, changes in metabolomics profiles were analysed to assess the effects of a Mediterranean diet, with and without probiotics, and a low-fat diet (according to World Health Organization recommendations) in 47 older adults (aged ≥60 years, 42.6% women) with mild cognitive impairment (MCI). The plasma metabolome was analysed using a quantitative LC-MS/MS targeted assay, and multivariate methods were employed to assess the impact of the diets on the plasma profile [3].

Sulforaphane and obesity-related metabolic dysfunction

Sulforaphane is a bioactive isothiocyanate derived primarily from broccoli and other cruciferous vegetables. A narrative review evaluates its antioxidant, anti-inflammatory and metabolic regulatory properties in the context of obesity, which is characterised by adipose tissue dysfunction, insulin resistance, chronic low-grade inflammation, oxidative stress, mitochondrial dysfunction and increased cardiometabolic risk. The review notes that limitations related to cost, adverse effects and long-term adherence have stimulated interest in complementary nutritional approaches [4].

Aflatoxin B₁ and glucose-lipid metabolism in fat-tailed ewes

Twenty non-pregnant, non-lactating multiparous Ghezel ewes were assigned to a control diet or the same basal diet supplemented with aflatoxin B₁-contaminated rice culture providing 500 µg AFB₁/kg dry matter for 40 days. Individual dry matter intake was not measured; however, all animals consumed the full daily ration, ensuring uniform nutrient intake. AFB₁ reduced measures of rumen fermentation, hepatic health, oxidative stress, inflammation and glucose-lipid metabolism [5]. This finding is animal-only.

Aluminium maltolate and the AMPK-PGC-1α-SIRT3 axis in HT22 cells

Mouse hippocampal neuronal HT22 cells were exposed to aluminium maltolate [Al(mal)₃, 60–240 µM] to investigate alterations in mitochondrial bioenergetics and senescence-associated pathways. Aluminium exposure significantly increased senescence-associated β-galactosidase (SA-β-gal) activity and upregulated p16 and p21 expression, accompanied by G2/M phase arrest [6]. This finding is in vitro.

Metformin withdrawal and metabolic flexibility in metabolic syndrome

A clinical trial is investigating how a short-term interruption of metformin treatment affects insulin sensitivity, glucose control and metabolic flexibility in adults with metabolic syndrome who are taking metformin as part of their usual medical treatment. Temporary interruptions may occur in real-life situations, such as missed doses, medication access problems, travel, or planned short-term discontinuation for clinical reasons. The study aims to understand whether stopping metformin for 14 days leads to rapid changes in glucose metabolism or whether the effects of previous metformin treatment may persist during a short period without the medication [7].

Sirtuin activators and weight management

Obesity is a chronic, multifactorial disease associated with a high burden of metabolic, cardiovascular and psychosocial complications. Despite extensive research, the long-term effectiveness of lifestyle-based weight-management strategies remains limited, and there is growing interest in molecular pathways that may enhance metabolic flexibility and improve treatment outcomes. Among these pathways, the sirtuin family — particularly SIRT1 and SIRT3 — has emerged as a target due to its involvement in mitochondrial biogenesis, energy expenditure, oxidative metabolism and the regulation of insulin sensitivity. Bioactive compounds that activate sirtuins include nicotinamide riboside [8].

Mitokines as bioenergetic stress signals

Cardiovascular disease is strongly influenced by mitochondrial dysfunction, yet how mitochondrial stress is communicated beyond the affected cell to coordinate systemic responses remains incompletely understood. Mitokines are stress-responsive signalling factors that link mitochondrial perturbation to cellular and inter-organ responses [9].

HACD1 and long-chain fatty acid metabolic reprogramming

Cancer stem cells are core drivers of esophageal cancer recurrence, metastasis and treatment resistance, and their metabolic reprogramming characteristics provide an entry point for targeted therapy. A study explored the role and regulatory mechanism of HACD1 (3-hydroxyacyl-CoA dehydrogenase) in this context [10].

If you are reading this for personal health reasons

The materials described here are sold for laboratory research only. We do not provide dosing or medical guidance. Anyone considering a compound for themselves should speak to a licensed clinician.

Sources

• [1] Evaluating Metabolic Health in Individuals With Extreme Obesity
• [2] Vitis Intervention Trial in Substrate Metabolism
• [3] Enhanced metabolic flexibility links Mediterranean diet with cognition: interim findings from a randomized controlled trial.
• [4] Sulforaphane and Broccoli-Derived Preparations in Obesity and Obesity-Related Metabolic Dysfunction: Mechanistic Insights, Preclinical Evidence, and Clinical Perspectives.
• [5] Impact of chronic dietary aflatoxin B1 intake on rumen fermentation, hepatic health, oxidative stress, inflammation, and glucose-lipid metabolism in fat-tailed ewes.
• [6] The AMPK-PGC-1α-SIRT3 axis mediates mitochondrial metabolic dysfunction and neuronal senescence induced by Al(mal)₃ exposure in HT22 hippocampal neuronal cells.
• [7] Metformin Withdrawal In Metabolic Syndrome
• [8] Sirtuin Activators and Weight Loss
• [9] Mitokines as bioenergetic stress signals in cardiovascular disease: mitochondrial communication, endocrine adaptation, and translational implications.
• [10] HACD1-driven long-chain fatty acid metabolic reprogramming enhances esophageal cancer tumorigenicity.